Medicure (MCUJF) Net Cash Flow (2010 - 2026)
Medicure's (MCUJF) quarterly Net Cash Flow came in at -$1.7 million in Q1 2026, down 9805.77% year-on-year from $17422.9 in Q1 2025, and down 4311.06% quarter-over-quarter from $40156.8 in Q4 2025.
Medicure (MCUJF) Net Cash Flow (2010 - 2026) Analysis & Trends
Medicure's Net Cash Flow history runs 17 years deep, the most recent figure standing at -$1.7 million for Q1 2026.
- On a quarterly basis, Net Cash Flow fell 9805.77% year-over-year to -$1.7 million in Q1 2026; TTM through Mar 2026 was -$3.9 million, a 1070.97% decrease from a year earlier, with the FY2025 full-year figure at -$2.2 million, down 1203.12% from the prior year.
- Net Cash Flow slipped to -$1.7 million in Q1 2026 per MCUJF's latest filing, from $40156.8 in the prior quarter.
- Across five years, Net Cash Flow topped out at $1.2 million in Q4 2024 and bottomed at -$1.8 million in Q2 2025.
- The 5-year median for Net Cash Flow is $28789.9 (2025), against an average of -$108352.9.
- Across the five-year window, Net Cash Flow soared 133.39% in 2024 and tumbled 9805.77% in 2026, its largest moves.
- Year by year, Net Cash Flow stood at $644833.6 in 2022, then fell by 17.19% to $534007.3 in 2023, then surged by 133.39% to $1.2 million in 2024, then sank by 96.78% to $40156.8 in 2025, then tumbled by 4311.06% to -$1.7 million in 2026.
- Per Business Quant, the three latest MCUJF Net Cash Flow figures stand at -$1.7 million (Q1 2026), $40156.8 (Q4 2025), and -$451240.3 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 202.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -526.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 711.50 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -277.40 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 461.90 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -446.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -112.00 Mn |
| 10 | Medicure | 8.77 Mn | 7.64 Mn | 2.57 Mn | -1.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.69 Mn |
| Mar 31, 2026 | -1.69 Mn |
| Dec 31, 2025 | 40,156.83 |
| Dec 31, 2025 | 40,156.83 |
| Sep 30, 2025 | -451,240.34 |
| Sep 30, 2025 | -451,240.34 |
| Jun 30, 2025 | -1.79 Mn |
| Jun 30, 2025 | -1.79 Mn |
| Mar 31, 2025 | 17,422.91 |
| Mar 31, 2025 | 17,422.91 |
| Dec 31, 2024 | 1.25 Mn |
| Dec 31, 2024 | 1.25 Mn |
| Sep 30, 2024 | -699,332.95 |
| Sep 30, 2024 | -699,332.95 |
| Jun 30, 2024 | -163,775.48 |
| Jun 30, 2024 | -163,775.48 |
| Mar 31, 2024 | -218,923.40 |
| Mar 31, 2024 | -218,923.40 |
| Dec 31, 2023 | 534,007.33 |
| Dec 31, 2023 | 534,007.33 |